Global Minimally Invasive Treatment Of Lung Cancer Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Minimally Invasive Treatment Of Lung Cancer Global Market Report 2025

Name: Minimally Invasive Treatment Of Lung Cancer Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Lung Tumor Ablation, Lung Tumor Embolization), By Stage (Stage I, Stage II, Stage III, Stage IV), By Age Group (Under 30 Years, 31 To 45 Years, 46 To 60 Years), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Minimally Invasive Treatment Of Lung Cancer Market Overview

• Minimally Invasive Treatment Of Lung Cancer market size has reached to $3.06 billion in 2024

• Expected to grow to $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%

• Growth Driver: Increasing Prevalence Of Lung Cancer Driving The Market Growth Due To Rising Global Incidence And Demand For Advanced Treatment Options

• Market Trend: Advancements In Minimally Invasive Lung Cancer Treatment Through Precision Navigation And Targeted Therapy

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Minimally Invasive Treatment Of Lung Cancer Market?

Minimally invasive lung cancer treatment involves using small incisions and advanced techniques, such as video-assisted or robotic surgery, to target or remove lung tumors while causing minimal damage to surrounding tissues. This approach aims to speed recovery, reduce complications, and enhance patient outcomes compared to traditional open surgery.

The main types of minimally invasive treatment for lung cancer are lung tumor ablation and lung tumor embolization. Lung tumor ablation is a procedure that destroys lung cancer cells by applying extreme heat or cold directly to the tumor using imaging-guided probes. This treatment affects patients across various stages, such as stages I, II, III, and IV, and age groups include under 30 years, 31–45 years, and 46–60 years. and treatments are used by several end-users, including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research institutions.

Minimally Invasive Treatment Of Lung Cancer Market Size and growth rate 2025 to 2029: Graph

What Is The Minimally Invasive Treatment Of Lung Cancer Market Size 2025 And Growth Rate?

What Is The Minimally Invasive Treatment Of Lung Cancer Market Growth Forecast?

The minimally invasive treatment of lung cancer market size is expected to see strong growth in the next few years. It will grow to $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for outpatient procedures, increasing investment in specialized lung cancer centers, greater availability of minimally invasive treatment options, government initiatives promoting advanced healthcare, and focus on reducing postoperative complications. Major trends in the forecast period include technology advancements in surgical instruments, innovations in patient monitoring systems, development of precision therapy techniques, research and development in less invasive interventions, and integration of artificial intelligence for treatment planning.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Minimally Invasive Treatment Of Lung Cancer Market Segmented?

1) By Type: Lung Tumor Ablation, Lung Tumor Embolization

2) By Stage: Stage I, Stage II, Stage III, Stage IV

3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years

4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions

Subsegments:

1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation

2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization

What Is Driving The Minimally Invasive Treatment Of Lung Cancer Market? Increasing Prevalence Of Lung Cancer Driving The Market Growth Due To Rising Global Incidence And Demand For Advanced Treatment Options

The increasing prevalence of lung cancer is expected to propel the growth of the minimally invasive treatment of lung cancer market going forward. Lung cancer is a type of cancer that originates in the lungs and is characterized by uncontrolled cell growth. Lung cancer is rising largely due to an increase in tobacco smoking, leading to an increased likelihood of uncontrolled cell growth and tumor formation. Minimally invasive treatment helps lung cancer patients by targeting and removing or destroying tumors through small incisions or imaging-guided probes, which reduces recovery time, minimizes damage to healthy lung tissue, lowers the risk of complications, and allows patients to resume normal activities sooner. For instance, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2022, the United States recorded 218,893 new cases of lung cancer, leading to deaths of 131,584 people in the country. Therefore, the increasing prevalence of lung cancer is driving the growth of the minimally invasive treatment of lung cancer industry.

Who Are The Major Players In The Global Minimally Invasive Treatment Of Lung Cancer Market?

Major companies operating in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Weill Cornell Medicine, Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Biodesix Inc., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH.

What Are The Key Trends Of The Global Minimally Invasive Treatment Of Lung Cancer Market? Advancements In Minimally Invasive Lung Cancer Treatment Through Precision Navigation And Targeted Therapy

Major companies operating in the minimally invasive treatment of the lung cancer market are focusing on developing advanced systems such as fluoroscopic navigation platforms to enhance accuracy and enable targeted, localized lung treatment. Fluoroscopic navigation platforms are medical imaging systems that integrate real-time fluoroscopy with navigation technology to precisely guide instruments to targeted lung areas, enabling minimally invasive biopsy and treatment of hard-to-reach lesions while reducing complications. For instance, in July 2022, Medtronic plc, an Ireland-based medical technology company, announced the first-in-world endoluminal lung ablation procedure using the ILLUMISITE. This minimally invasive procedure, performed by physicians in Hong Kong, used the ILLUMISITE platform to accurately navigate through a patient's lungs with a customized virtual pathway based on their CT scan. The platform's navigation catheter helped guide the bronchoscope to the lung lesion, where a specialized ablation catheter delivered targeted treatment. This innovation represents a significant milestone in lung mass diagnosis and treatment, combining precise navigation with localized ablation technology.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Minimally Invasive Treatment Of Lung Cancer Market? Toulouse University Hospital Acquired Epione From Quantum Surgical To Enhance Minimally Invasive Lung Tumor Treatments

In February 2025, the Toulouse University Hospital, a France-based medical institution, acquired Epione from Quantum Surgical for an undisclosed amount. With this acquisition, the Toulouse University Hospital aims to enhance its capacity for minimally invasive, robot-assisted treatment of abdominal and lung tumors, enabling physicians to perform highly precise procedures, improving patient outcomes, reducing recovery times, and expanding access to advanced oncological care in the Occitanie region. Quantum Surgical is a France-based medical technology company that offers minimally invasive management for small and hard-to-reach lung tumors.

What Is The Regional Outlook For The Global Minimally Invasive Treatment Of Lung Cancer Market?

North America was the largest region in the minimally invasive treatment of lung cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Minimally Invasive Treatment Of Lung Cancer Market?

The minimally invasive treatment of lung cancer market consists of revenues earned by entities by providing services such as diagnostic imaging, bronchoscopic procedures, chemotherapy delivery, targeted therapy administration and postoperative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive treatment of lung cancer market also includes of sales of implants, catheters, endoscopes, navigation systems and imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Minimally Invasive Treatment Of Lung Cancer Industry?

The minimally invasive treatment of lung cancer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive treatment of lung cancer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Minimally Invasive Treatment Of Lung Cancer Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.35 billion
Revenue Forecast In 2034	$4.78 billion
Growth Rate	CAGR of 9.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Type, Stage, Age Group, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Weill Cornell Medicine, Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Biodesix Inc., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Minimally Invasive Treatment Of Lung Cancer Market Characteristics

3. Minimally Invasive Treatment Of Lung Cancer Market Trends And Strategies

4. Minimally Invasive Treatment Of Lung Cancer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Minimally Invasive Treatment Of Lung Cancer Growth Analysis And Strategic Analysis Framework

5.1. Global Minimally Invasive Treatment Of Lung Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Minimally Invasive Treatment Of Lung Cancer Market Growth Rate Analysis

5.4. Global Minimally Invasive Treatment Of Lung Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Minimally Invasive Treatment Of Lung Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Minimally Invasive Treatment Of Lung Cancer Total Addressable Market (TAM)

6. Minimally Invasive Treatment Of Lung Cancer Market Segmentation

6.1. Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Tumor Ablation

Lung Tumor Embolization

6.2. Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stage I

Stage II

Stage III

Stage IV

6.3. Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Under 30 Years

31 To 45 Years

46 To 60 Years

6.4. Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ambulatory Surgical Centers (ASCs)

Specialty Clinics

Research Institutions

6.5. Global Minimally Invasive Treatment Of Lung Cancer Market, Sub-Segmentation Of Lung Tumor Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Radiofrequency Ablation

Microwave Ablation

Cryoablation

Laser Ablation

6.6. Global Minimally Invasive Treatment Of Lung Cancer Market, Sub-Segmentation Of Lung Tumor Embolization, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bronchial Artery Embolization

Pulmonary Artery Embolization

Chemoembolization

Radioembolization

7. Minimally Invasive Treatment Of Lung Cancer Market Regional And Country Analysis

7.1. Global Minimally Invasive Treatment Of Lung Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Minimally Invasive Treatment Of Lung Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market

8.1. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Minimally Invasive Treatment Of Lung Cancer Market

9.1. China Minimally Invasive Treatment Of Lung Cancer Market Overview

9.2. China Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Minimally Invasive Treatment Of Lung Cancer Market

10.1. India Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Minimally Invasive Treatment Of Lung Cancer Market

11.1. Japan Minimally Invasive Treatment Of Lung Cancer Market Overview

11.2. Japan Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Minimally Invasive Treatment Of Lung Cancer Market

12.1. Australia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Minimally Invasive Treatment Of Lung Cancer Market

13.1. Indonesia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Minimally Invasive Treatment Of Lung Cancer Market

14.1. South Korea Minimally Invasive Treatment Of Lung Cancer Market Overview

14.2. South Korea Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Minimally Invasive Treatment Of Lung Cancer Market

15.1. Western Europe Minimally Invasive Treatment Of Lung Cancer Market Overview

15.2. Western Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Minimally Invasive Treatment Of Lung Cancer Market

16.1. UK Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Minimally Invasive Treatment Of Lung Cancer Market

17.1. Germany Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Minimally Invasive Treatment Of Lung Cancer Market

18.1. France Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Minimally Invasive Treatment Of Lung Cancer Market

19.1. Italy Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Minimally Invasive Treatment Of Lung Cancer Market

20.1. Spain Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market

21.1. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market Overview

21.2. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Minimally Invasive Treatment Of Lung Cancer Market

22.1. Russia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Minimally Invasive Treatment Of Lung Cancer Market

23.1. North America Minimally Invasive Treatment Of Lung Cancer Market Overview

23.2. North America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Minimally Invasive Treatment Of Lung Cancer Market

24.1. USA Minimally Invasive Treatment Of Lung Cancer Market Overview

24.2. USA Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Minimally Invasive Treatment Of Lung Cancer Market

25.1. Canada Minimally Invasive Treatment Of Lung Cancer Market Overview

25.2. Canada Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Minimally Invasive Treatment Of Lung Cancer Market

26.1. South America Minimally Invasive Treatment Of Lung Cancer Market Overview

26.2. South America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Minimally Invasive Treatment Of Lung Cancer Market

27.1. Brazil Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Minimally Invasive Treatment Of Lung Cancer Market

28.1. Middle East Minimally Invasive Treatment Of Lung Cancer Market Overview

28.2. Middle East Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Minimally Invasive Treatment Of Lung Cancer Market

29.1. Africa Minimally Invasive Treatment Of Lung Cancer Market Overview

29.2. Africa Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Minimally Invasive Treatment Of Lung Cancer Market Competitive Landscape And Company Profiles

30.1. Minimally Invasive Treatment Of Lung Cancer Market Competitive Landscape

30.2. Minimally Invasive Treatment Of Lung Cancer Market Company Profiles

30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Minimally Invasive Treatment Of Lung Cancer Market Other Major And Innovative Companies

31.1. Olympus Corporation

31.2. Intuitive Surgical Inc.

31.3. Weill Cornell Medicine

31.4. Accuray Incorporated

31.5. Richard Wolf GmbH

31.6. AngioDynamics Inc.

31.7. CMR Surgical Ltd.

31.8. Biodesix Inc.

31.9. Guangzhou Geyi Medical Instrument Co. Ltd.

31.10. Quantum Surgical SA

31.11. Scanlan International Inc.

31.12. RZ Medizintechnik GmbH & Co. KG

31.13. August Reuchlen GmbH

31.14. SBH Surgical GmbH & Co. KG

31.15. Geister Medizintechnik GmbH

32. Global Minimally Invasive Treatment Of Lung Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Minimally Invasive Treatment Of Lung Cancer Market

34. Recent Developments In The Minimally Invasive Treatment Of Lung Cancer Market

35. Minimally Invasive Treatment Of Lung Cancer Market High Potential Countries, Segments and Strategies

35.1 Minimally Invasive Treatment Of Lung Cancer Market In 2029 - Countries Offering Most New Opportunities

35.2 Minimally Invasive Treatment Of Lung Cancer Market In 2029 - Segments Offering Most New Opportunities

35.3 Minimally Invasive Treatment Of Lung Cancer Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Minimally Invasive Treatment Of Lung Cancer Market, Sub-Segmentation Of Lung Tumor Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Minimally Invasive Treatment Of Lung Cancer Market, Sub-Segmentation Of Lung Tumor Embolization, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Minimally Invasive Treatment Of Lung Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Minimally Invasive Treatment Of Lung Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Johnson & Johnson Financial Performance

Table 78: Medtronic plc Financial Performance

Table 79: Siemens Healthineers AG Financial Performance

Table 80: Stryker Corporation Financial Performance

Table 81: Boston Scientific Corporation Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Minimally Invasive Treatment Of Lung Cancer Market, Sub-Segmentation Of Lung Tumor Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Minimally Invasive Treatment Of Lung Cancer Market, Sub-Segmentation Of Lung Tumor Embolization, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Minimally Invasive Treatment Of Lung Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Minimally Invasive Treatment Of Lung Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Johnson & Johnson Financial Performance

Figure 78: Medtronic plc Financial Performance

Figure 79: Siemens Healthineers AG Financial Performance

Figure 80: Stryker Corporation Financial Performance

Figure 81: Boston Scientific Corporation Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Consumer Credit Global Market Report 2025 – By Service Type (Credit Services, Software And IT Support Services), By Credit Type (Revolving Credits, Non-Revolving Credits), By Issuer (Banks And Finance Companies, Credit U...

Credit Card Issuance Services Global Market Report 2025 – By Type (Consumer Credit Cards, Business Credit Cards), By Issuers (Banks, Credit Unions, Non-Banking Financial Companies), By End-User (Personal, Business) – Imp...

Personal Goods Repair And Maintenance Global Market Report 2025 – By Type (Home And Garden Equipment Repair And Maintenance, Appliance Repair And Maintenance, Reupholstery And Furniture Repair, Footwear And Leather Goods...

Payment as a Service Global Market Report 2025 – By Service( Professional Services, Managed Services ), By Component( Platform, Services ), By Vertical( Retail, Hospitality, Media and entertainment, Healthcare, Banking, ...

Payer Services Global Market Report 2025 –By Outsourcing Services (Business Process Outsourcing Services, Knowledge Process Outsourcing Services, Information Technology Outsourcing Services), By Application (Revenue Cycl...

Payment as a Service Global Market Report 2025 – By Service( Professional Services, Managed Services ), By Component( Platform, Services ), By Vertical( Retail, Hospitality, Media and entertainment, Healthcare, Banking, ...

Payment Processing Solutions Global Market Report 2025 – By Payment Method( eWallet, Credit card, Debit card, Automatic clearing house, Other Methods), By Deployment Type( On-premises, Cloud-based), By Vertical( Banking,...

Frequently Asked Questions

What is the definition of the Minimally Invasive Treatment Of Lung Cancer market?

How will the Minimally Invasive Treatment Of Lung Cancer market drivers and restraints affect the market dynamics? What forces will shape the Minimally Invasive Treatment Of Lung Cancer industry going forward?

The market major growth driver - Increasing Prevalence Of Lung Cancer Driving The Market Growth Due To Rising Global Incidence And Demand For Advanced Treatment Options. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Minimally Invasive Treatment Of Lung Cancer market?

The minimally invasive treatment of lung cancer market size has grown strongly in recent years. It will grow from $3.06 billion in 2024 to $3.35 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of lung cancer, rising awareness about minimally invasive procedures, a growing geriatric population, adoption of early diagnosis methods, and expansion of healthcare infrastructure. The minimally invasive treatment of lung cancer market size is expected to see strong growth in the next few years. It will grow to $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for outpatient procedures, increasing investment in specialized lung cancer centers, greater availability of minimally invasive treatment options, government initiatives promoting advanced healthcare, and focus on reducing postoperative complications. Major trends in the forecast period include technology advancements in surgical instruments, innovations in patient monitoring systems, development of precision therapy techniques, research and development in less invasive interventions, and integration of artificial intelligence for treatment planning. For further insights on this market, request a sample here

How is the Minimally Invasive Treatment Of Lung Cancer market segmented?

The minimally invasive treatment of lung cancer market covered in this report is segmented
1) By Type: Lung Tumor Ablation, Lung Tumor Embolization
2) By Stage: Stage I, Stage II, Stage III, Stage IV
3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years
4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions Subsegments:
1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation
2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization For further insights on this market, request a sample here

Which region has the largest share of the Minimally Invasive Treatment Of Lung Cancer market? What are the other regions covered in the report?

North America was the largest region in the minimally invasive treatment of lung cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive treatment of lung cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Minimally Invasive Treatment Of Lung Cancer market?

What are the key trends in the Minimally Invasive Treatment Of Lung Cancer market?

Major trends in this market include Advancements In Minimally Invasive Lung Cancer Treatment Through Precision Navigation And Targeted Therapy. For further insights on this market, request a sample here.